These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9111321)

  • 1. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4.
    Wu RY; Zhang Y; Feng XH; Derynck R
    Mol Cell Biol; 1997 May; 17(5):2521-8. PubMed ID: 9111321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.
    Feng XH; Zhang Y; Wu RY; Derynck R
    Genes Dev; 1998 Jul; 12(14):2153-63. PubMed ID: 9679060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
    Zhang Y; Musci T; Derynck R
    Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4.
    Morén A; Itoh S; Moustakas A; Dijke P; Heldin CH
    Oncogene; 2000 Sep; 19(38):4396-404. PubMed ID: 10980615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
    Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
    Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of the transforming growth factor-beta -induced Smad3/c-Jun transcriptional cooperativity.
    Qing J; Zhang Y; Derynck R
    J Biol Chem; 2000 Dec; 275(49):38802-12. PubMed ID: 10995748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential ubiquitination defines the functional status of the tumor suppressor Smad4.
    Morén A; Hellman U; Inada Y; Imamura T; Heldin CH; Moustakas A
    J Biol Chem; 2003 Aug; 278(35):33571-82. PubMed ID: 12794086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
    Lin X; Liang M; Liang YY; Brunicardi FC; Melchior F; Feng XH
    J Biol Chem; 2003 May; 278(21):18714-9. PubMed ID: 12621041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
    Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
    J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter.
    Song CZ; Siok TE; Gelehrter TD
    J Biol Chem; 1998 Nov; 273(45):29287-90. PubMed ID: 9792626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
    Kuang C; Chen Y
    Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling.
    Ueki N; Hayman MJ
    J Biol Chem; 2003 Aug; 278(35):32489-92. PubMed ID: 12857746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
    Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
    J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear targeting of transforming growth factor-beta-activated Smad complexes.
    Chen HB; Rud JG; Lin K; Xu L
    J Biol Chem; 2005 Jun; 280(22):21329-36. PubMed ID: 15799969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4.
    Jones JB; Kern SE
    Nucleic Acids Res; 2000 Jun; 28(12):2363-8. PubMed ID: 10871368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta signaling in colon cancer cells.
    Li F; Cao Y; Townsend CM; Ko TC
    World J Surg; 2005 Mar; 29(3):306-11. PubMed ID: 15711891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4.
    Chou WC; Prokova V; Shiraishi K; Valcourt U; Moustakas A; Hadzopoulou-Cladaras M; Zannis VI; Kardassis D
    Mol Biol Cell; 2003 Mar; 14(3):1279-94. PubMed ID: 12631740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.